ReviewJournal of experimental & clinical cancer research : CR2022

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.

Peijie Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.